“Baseline and Dynamic Changes in Skeletal Muscle Mass As Predictive Biomarkers in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab: Predictive Value of Sarcopenia in MRCC”. Radiology and Oncology 59, no. 4 (December 16, 2025): 624–634. Accessed October 1, 2026. https://www.radioloncol.com/index.php/ro/article/view/4685.